에 대한 최신 뉴스 AGM Gr Hldgs (NASDAQ:AGMH) 주식

AGM Gr Hldgs

AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

AGM Group Holdings Inc. - Class A Ordinary Shares

AGM Group Holdings Inc

Cherry Hill Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHMI#NYSE">CHMI</a>) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.12 by 16.67 percent. This is a 41.18 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $660.00 thousand which missed the analyst consensus estimate of $12.21 million by 94.59 percent. This is a 269.23 percent increase over sales of $(390.00 thousand) the same period last year.

Earnings

Earnings Misses

News

CHMI

Cherry Hill Mortgage Q4 Adj EPS $0.10 Misses $0.12 Estimate, Sales $660.00K Miss $12.21M Estimate

Earnings Beats

TOVX

Theriva Biologics FY 2024 GAAP EPS $(19.03) Beats $(24.11) Estimate

Guidance

APEI

American Public Education Expects 2025 Consolidated Revenue Of $650M – $660M (Est $648.457M)

Serve Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 52.08 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $175.84 thousand which missed the analyst consensus estimate of $246.40 thousand by 28.64 percent. This is a 311.62 percent increase over sales of $42.72 thousand the same period last year.

SERV

Serve Robotics Q4 Adj EPS $(0.23) Misses $(0.18) Estimate, Sales $175.84K Miss $246.40K Estimate

<a href="https://www.globenewswire.com/Tracker?data=4-wEYY8qTpIGWlIctlJfnBFxXQNFzpgfzwaTBHqZaqRbPNNJpdrrXVq_JBxT9srrNqcHr7Aky4r7thPf37u-sPllobxn_WjSNceYTBx3zMQ=">Centessa Pharmaceuticals</a> plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTA#NASDAQ">CNTA</a>), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that data from the Phase 1 clinical trial of ORX750, an investigational novel highly potent and selective OX2R agonist being progressed for the treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH), will be presented in a poster session&nbsp;at the American Academy of Neurology (AAN) 2025 Annual Meeting being held April 5-9, 2025, in San Diego, CA. ORX750 is being evaluated in an ongoing Phase 2a clinical trial (CRYSTAL-1) in participants with NT1, NT2 and IH.
Details of the poster presentation are as follows: Title: Phase 1 Clinical Data with Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Participants Abstract Number: 2277 Presenter: Deborah Hartman, PhD, Global Scientific Head, Orexin Program Session Date and Time: Saturday, April 5, 2025, at 11:45 AM- 12:45 PM PT
Centessa's booth number is 627. AAN abstracts are available on the conference website. Centessa's poster will be available on the Centessa website at <a href="https://www.globenewswire.com/Tracker?data=K0Vfn9T9KiqgoRVG4dMoz3GF2YubgLSiu-TT9QQWhy_QM7jYgxa8fo3iywxABZNmKI7OLQyQLDpemEwzVxfObnQndDm0CADrehKppreC60rTBfvoWAb9vxS2-MixnT4eN6Lqiby7DwMFY3JI_qiT4SwMIgaeCV_Aw0EF3iVZcPOjEzin7DMJvi0fv2Sqhibhm0qVUhO91DRFMV15kPWjYA==">https://investors.centessa.com/events-presentations</a>&nbsp;after the poster presentation concludes.

Biotech

General

CNTA

Centessa Pharmaceuticals Announces Poster Presentation Of Phase 1 Clinical Data For ORX750, A Novel Orexin Receptor 2 Agonist, At The AAN 2025 Annual Meeting

a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) sees FY2025 sales of $600.000 million-$610.000 million vs $599.69 million analyst estimate.

a.k.a. Brands Holding Sees FY2025 Sales $600.000M-$610.000M vs $599.69M Est

a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) sees Q1 sales of $121.000 million-$124.000 million vs $120.95 million analyst estimate.

a.k.a. Brands Holding Sees Q1 Sales $121.000M-$124.000M vs $120.95M Est

American Public Education Expects Q1 Consolidated Revenue Of $161M – $163M (Est $161.95M), EPS Of $0.09 – $0.17 (Est $0.35)

Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.37 by 45.95 percent. The company reported quarterly sales of $4.10 billion which beat the analyst consensus estimate of $4.07 billion by 0.66 percent. This is a 4.61 percent decrease over sales of $4.30 billion the same period last year.

Gap Q4 2024 Adj EPS $0.54 Beats $0.37 Estimate, Sales $4.10B Beat $4.07B Estimate

ORKA

Oruka Therapeutics Q4 2024 GAAP EPS $(0.49) Beats $(0.79) Estimate

a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate of $(0.12) by 633.33 percent. This is a 183.87 percent decrease over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $159.02 million which beat the analyst consensus estimate of $158.98 million by 0.03 percent. This is a 6.79 percent increase over sales of $148.91 million the same period last year.

a.k.a. Brands Holding Q4 EPS $(0.88) Misses $(0.12) Estimate, Sales $159.02M Beat $158.98M Estimate

Management

loanDepot Frank Martell Steps Down As CEO; Hsieh To Serve As Interim CEO Until New CEO Appointed

Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.52 by 1.92 percent. This is a 10.87 percent increase over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $289.48 million which beat the analyst consensus estimate of $285.54 million by 1.38 percent. This is a 20.17 percent increase over sales of $240.90 million the same period last year.

GWRE

Guidewire Software Q2 2025 Adj EPS $0.51 Misses $0.52 Estimate, Sales $289.48M Beat $285.54M Estimate

GEN Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENK#NASDAQ">GENK</a>) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 300 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $54.65 million which beat the analyst consensus estimate of $49.77 million by 9.81 percent. This is a 21.16 percent increase over sales of $45.11 million the same period last year.

GENK

GEN Restaurant Gr Q4 GAAP EPS $(0.04) Misses $(0.03) Estimate, Sales $54.65M Beat $49.77M Estimate

Potbelly (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBPB#NASDAQ">PBPB</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.07 by 85.71 percent. This is a 550 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $116.63 million which beat the analyst consensus estimate of $116.37 million by 0.22 percent. This is a 7.25 percent decrease over sales of $125.75 million the same period last year.

PBPB

Potbelly Q4 Adj EPS $0.13 Beats $0.07 Estimate, Sales $116.63M Beat $116.37M Estimate

Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) sees Q1 sales of $11.923 million vs $12.13 million analyst estimate.

MCHX

Marchex Sees Q1 Sales $11.923M vs $12.13M Est

Las Vegas Sands Announces Robert G. Goldstein, Its Chairman And Chief Executive Officer Will Transition To Role Of Senior Advisor On March 1, 2026\

Xtant Medical Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/XTNT#AMEX">XTNT</a>) sees FY2025 sales of $126.000 million-$130.000 million vs $132.85 million analyst estimate.

XTNT

Xtant Medical Hldgs Sees FY2025 Revenue of $126.000M-$130.000M vs $132.85M Est

Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. The company reported quarterly sales of $11.92 million which missed the analyst consensus estimate of $12.01 million by 0.74 percent. This is a 3.81 percent decrease over sales of $12.39 million the same period last year.

Marchex Q4 Adj EPS $(0.03) Misses $(0.02) Estimate, Sales $11.92M Miss $12.01M Estimate

Kronos Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRO#NYSE">KRO</a>) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $0.11 by 209.09 percent. This is a 140 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $423.100 million which missed the analyst consensus estimate of $494.264 million by 14.40 percent. This is a 5.75 percent increase over sales of $400.100 million the same period last year.

Kronos Worldwide Q4 2024 GAAP EPS $(0.12) Misses $0.11 Estimate, Sales $423.100M Miss $494.264M Estimate

Fintech

Press Releases

AGM Group Receives Notification from Nasdaq Relating Delayed Filing of Form 20-F

AGM Group Announces Receipt of Notification from Nasdaq

AGM Group Holdings Inc. Appoints New Chief Executive Officer of Canadian Subsidiary to Expand in North American Crypto and Blockchain Market

Commodities

AGM Group Holdings Inc. Enters into Partnership Agreement with Nowlit to Facilitate Expansion in AI and Crypto Markets

AGM Group Holdings Inc. Announces Investment in Bitcoin Mining Equipment

AGM Group Holdings Inc. Announces Strategic Partnership with Canada's Nowlit to Expand High-Performance Computing Capabilities

AGM Group Holdings Inc. Highlights Strategic Growth and Future Initiatives in AI and Cryptocurrency

AGM Group Holdings Inc. Announces Strategic Partnership with HashBeaver to Drive Blockchain and AI Innovation

AGM Group Holdings Inc. Announces Pricing of $5.4 Million Public Offering

AGM Group Holdings Inc. Announces Closing of $5.4 Million Offering

AGMH

Bakkt Holdings, Inc. Class A Common Stock

Bakkt Hldgs

CME Group

Coincheck Group

Coinbase Global, Inc. - Class A Common Stock

Coinbase Global

Donnelley Financial Solutions, Inc. Common Stock

Donnelley Financial Solns

FactSet Research Systems Inc. Common Stock

FactSet Research Systems

Intercontinental Exchange Inc. Common Stock

Intercontinental Exchange

Open Lending

Moodys

Marketwise

MarketAxess Holdings, Inc. - Common Stock

MarketAxess Holdings

Morningstar

MSCI

Nasdaq

Powell Max Limited - Class A Ordinary Shares

Powell Max

S&P Global

Tradeweb Markets Inc. - Class A Common Stock

Comments

AGM Gr Hldgs

뉴스

에 대한 최신 뉴스 AGM Gr Hldgs (NASDAQ:AGMH) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌